AQOMTI

Welcome to the Brand page for “AQOMTI”, which is offered here for Human pharmaceutical preparations for the prevention and treatment of viral diseases, autoimmune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives;.

Its status is currently believed to be active. Its class is unavailable. “AQOMTI” is believed to be currently owned by “Johnson & Johnson”.